Protection against Gram-Negative Bacteremia with Antiserum to Endotoxins

  • Abraham I. Braude
  • Elizabeth J. Ziegler


Although the mechanisms of the toxic and immunologic properties of endotoxins have been extensively examined by many investigators, only a few have worked on the possible value of an antitoxin against endotoxins. There have been at least two deterrents to such research that might explain the lag in development of an antitoxin to these lipopolysaccharide (LPS) poisons of gram-negative bacteria. The first is the question of whether or not LPS causes, or contributes to, the toxic manifestations of gram-negative bacterial infections. Until the role of LPS in human infection appeared to be a reasonable possibility, there would be little justification for undertaking the task of developing an antitoxin against LPS for human use. The second deterrent is related to the apparent antigenic heterogeneity of the endotoxins in the many species and serotypes of pathogenic gram-negative bacteria. It would seem impractical, on first consideration, to prepare antisera against each of the different serotypes of O antigens presented by all these gram-negative bacteria.


Gamma Globulin Passive Immunization Core Oligosaccharide Shwartzman Reaction Renal Cortical Necrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Atkins, E., and Bodel, P., 1972, Fever, N. Engl. J. Med. 286:27.PubMedCrossRefGoogle Scholar
  2. Borden, C., and Hall, W., 1951, Fatal transfusion reactions from massive bacterial contamination of blood, N. Engl. J. Med. 245:760.PubMedCrossRefGoogle Scholar
  3. Braude, A., 1958, Transfusion reactions from contaminated blood, N. Engl. J. Med. 258: 1289.PubMedCrossRefGoogle Scholar
  4. Braude, A., and Douglas, H., 1972, Passive immunization against the local Shwartzman reaction, J. Immunol. 108:505.PubMedGoogle Scholar
  5. Braudc, A., Douglas, H., and Joncs, J., 1969, Experimental production of lethal Escherichia coli bacteremia of pelvic origin, J. Bacteriol. 98:979.Google Scholar
  6. Braude, A., Douglas, H., and Davis, C., 1973, Treatment and prevention of intravascular coagulation with antiserum to endotoxin,J. Infect. Dis. 128(Suppl.):157.PubMedCrossRefGoogle Scholar
  7. Brues, A., and Shear, M., 1944, Reactions of four patients with advanced malignant tumors to injections of a polysaccharide from Serratia marcescens culture filtrate,J. Natl. Cancer Inst. 5:95.Google Scholar
  8. Bruins, S. C., Stumacher, R., Johns, M. A., and McCabe, W. R., 1977, Immunization with R mutants of Salmonella minnesota. III. Comparison of the protective effect of immunization with lipid A and the Re mutant, Infect. Immun. 17:16.PubMedGoogle Scholar
  9. Chedid, L., Parant, M., Parant, F., and Boyer, F., 1968, A proposed mechanism for natural immunity to enterobacterial pathogens,J. Immunol. 100:292.PubMedGoogle Scholar
  10. Davis, C., and Arnold, K., 1974, Role of endotoxin in meningococcal purpura,J. Exp. Med. 140:159.PubMedCrossRefGoogle Scholar
  11. Davis, C., Brown, K., Douglas, H., Tate, W., and Braude, A., 1969, Prevention of death from endotoxin with antisera. I. The risk of fatal anaphylaxis to endotoxin,J. Immunol. 102:563.PubMedGoogle Scholar
  12. Davis, C., Ziegler, E., and Arnold, K., 1978, Neutralization of meningococcal endotoxin by antibody to core glycolipid,J. Exp. Med. 147:1007.PubMedCrossRefGoogle Scholar
  13. Freedman, H., 1959, Passive transfer of protection against lethality of homologous and heterologous endotoxins, Proc. Soc. Exp. Biol. Med. 102:504.PubMedGoogle Scholar
  14. Freedman, H., 1960, Further studies on passive transfer of tolerance to pyrogenicity of bacterial endotoxin: The febrile and leucopenic responses,J. Exp. Med. 112:619.PubMedCrossRefGoogle Scholar
  15. Galanos, C., Freudenberg, M., Hase, S., Jay, F., and Ruschmann, E., 1977, Biological activities and immunological properties of lipid A, in: Microbiology 1977 (D. Schicssinger, ed.), American Society for Microbiology, Washington, D.C.Google Scholar
  16. Greisman, S., and Hornick, R., 1973, Mechanisms of endotoxin tolerance with special references to man,J. Infect. Dis. 128(Suppl.):257.CrossRefGoogle Scholar
  17. Greisman, S. E., DuBuy, J., and Woodward, C., 1978, Experimental gram-negative sepsis: Reevaluation of the ability of rough mutant antisera to protect mice, Proc. Soc. Exp. Biol. Med. 158:482.PubMedGoogle Scholar
  18. Hodgin, L., and Dreivs, J., 1976, Effect of active and passive immunization with lipid A and Salmonella minnesota Re 595 on gram-negative infections in mice, Infection 4:5.PubMedCrossRefGoogle Scholar
  19. Lee, L., and Stetson, C., 1965, The local and generalized Shwartzman phenomenon, in: The Inflammatory Process (B. W. Zweifoch, L. Grant, and R. T. McCluskey, eds.), p. 791, Academic Press, New York.Google Scholar
  20. Lüderitz, O., 1977, Endotoxins and other cell wall components of gram-negative bacteria and their biological properties, in: Microbiology 1977 (D. Schlessinger, ed.), American Society for Microbiology, Washington, D.C.Google Scholar
  21. Lüderitz, O., Staub, A., and Westphal, O., 1966, Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae, Bacteriol. Rev. 30:192.PubMedGoogle Scholar
  22. McCabe, W., 1972, Immunization with R mutants of S. minnesota, J. Immunol. 108:601.Google Scholar
  23. Marks, M., Ziegler, E., Douglas, H., Corbeil, L., and Braude, A., 1982, Induction of immunity against Haemophilus influenzae type B infection by Escherichia coli core lipopolysaccharide,J. Clin. Invest. 69:742.PubMedCrossRefGoogle Scholar
  24. Milner, K., 1973, Patterns of tolerance to endotoxin,J. Infect. Dis. 128(Suppl.):229.CrossRefGoogle Scholar
  25. Morrison, D., and Ulevitch, R., 1978, The effects of bacterial endotoxins on host mediation systems: A review, Am. J. Pathol. 93:527.Google Scholar
  26. Nikaido, H., 1973, Biosynthesis and assembly of lipopolysaccharide and the outer membrane layer of gram-negative cell wall, in: Bacterial Membranes and Walls (Leive L., ed.), Dekker, New York.Google Scholar
  27. Spink, W., Braude, A., Castaneda, M. R., and Goytia, R., 1948, Aureomycin therapy in human brucellosis due to Brucella melitensis, J. Am. Med. Assoc. 138:1145.PubMedCrossRefGoogle Scholar
  28. Stevens, A., Legg, J., Henry, B., Bille, J., Kirby, W., and Finch, C., 1953, Fatal transfusion reactions from contamination of stored blood by cold growing bacteria, Ann. Intern. Med. 39:1228.PubMedGoogle Scholar
  29. Wolf, J., McCutchan, J., Ziegler, E., and Braude, A., 1979, Prophylactic antibody to core lipopolysaccharide in neutropenic patients, Proc. 11th Int. Congr. Chemother. 19th Intersci. Conf. Antimimicrob. Agents Chemother. 19:65.Google Scholar
  30. Young, L., Stevens, P., and Ingram, J., 1978, Functional role of antibody against “core” glycolipid of Enterobacteriaceae, J. Clin. Invest. 56:850.CrossRefGoogle Scholar
  31. Ziegler, E., and Douglas, H., 1979, Pseudomonas vasculitis and bacteremia following conjunctivitis: A simple model of fatal Pseudomonas infection in neutropenia, J. Infect. Dis. 139:228.CrossRefGoogle Scholar
  32. Ziegler, E., Douglas, H., and Braude, A., 1973a, Human antiserum for prevention of the local Shwartzman reaction and death from bacterial lipopolysaccharides,J. Clin. Invest. 52:3236.PubMedCrossRefGoogle Scholar
  33. Ziegler, E. J., Douglas, H., Sherman, J. E., Davis, C. E., and Braude, A. I., 1973b, Treatment of E. coli and Klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-Gal-epimerase-deficient mutant,J. Immunol. 111:433.PubMedGoogle Scholar
  34. Ziegler, E. J., McCutchan, J. A., Douglas, H., and Braude, A., 1975, Prevention of lethal Pseudomonas bacteremia with epimerase-deficient E. coli antiserum, Trans. Assoc. Am. Physicians 88:101.PubMedGoogle Scholar
  35. Ziegler, E. J., McCutchan, J. A., and Braude, A. I., 1978, Clinical trial of core glycolipid antibody in gram-negative bacteremia, Trans, Assoc. Am. Physicians 91:253.Google Scholar
  36. Ziegler, E., McCutchan, J. A., Fierer, J., Glauser, M., Sadoff, J. C., Douglas, H., and Braude, A. E, 1982, Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli, X. Engl. J. Med. 307:1225.Google Scholar
  37. Zinner, S., and McCabe, W., 1976, Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli,J. Infect. Dis. 133:32.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Abraham I. Braude
    • 1
  • Elizabeth J. Ziegler
    • 1
  1. 1.Department of Medicine and PathologyUniversity of CaliforniaSan DiegoUSA

Personalised recommendations